Eosinophils Increase Neuron Branching in Human and Murine Skin and In Vitro by Foster, Erin L. et al.
Eosinophils Increase Neuron Branching in Human and
Murine Skin and In Vitro
Erin L. Foster
1, Eric L. Simpson
2, Lorna J. Fredrikson
3, James J. Lee
3, Nancy A. Lee
3, Allison D. Fryer
4,
David B. Jacoby
4*
1Department of Molecular Microbiology and Immunology, Oregon Health & Science University, Portland, Oregon, United States of America, 2Department of
Dermatology, Oregon Health & Science University, Portland, Oregon, United States of America, 3Department of Biochemistry, Mayo Clinic, Scottsdale, Arizona, United
States of America, 4Division of Pulmonary and Critical Care, Department of Medicine, Oregon Health & Science University, Portland, Oregon, United States of America
Abstract
Cutaneous nerves are increased in atopic dermatitis, and itch is a prominent symptom. We studied the functional
interactions between eosinophils and nerves in human and mouse skin and in culture. We demonstrated that human atopic
dermatitis skin has eosinophil granule proteins present in the same region as increased nerves. Transgenic mice in which
interleukin-5 (IL-5) expression is driven by a keratin-14 (K14) promoter had many eosinophils in the epidermis, and the
number of nerves was also significantly increased in the epidermis. In co-cultures, eosinophils dramatically increased
branching of sensory neurons isolated from the dorsal root ganglia (DRG) of mice. This effect did not occur in DRG neurons
co-cultured with mast cells or with dead eosinophils. Physical contact of the eosinophils with the neurons was not required,
and the effect was not blocked by an antibody to nerve growth factor. DRG neurons express eotaxin-1, ICAM-1 and VCAM-1,
which may be important in the recruitment, binding, and activation of eosinophils in the region of cutaneous nerves. These
data indicate a pathophysiological role for eosinophils in cutaneous nerve growth in atopic dermatitis, and suggest they
may present a therapeutic target in atopic dermatitis and other eosinophilic skin conditions with neuronal symptoms such
as itch.
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Introduction
Atopic dermatitis is characterized by itch, which greatly affects
the quality of life of patients [Jacquet, 1904 and [1]]. The itch
often begins before any lesions appear, and marks on the skin can
be limited to excoriations, or scratches, made by the patient.
Patients with atopic dermatitis experience itch instead of pain
when tested with mechanical, electrical, low pH, or heat stimuli
[2]. The sensory neurons that transmit itch are primary afferents
whose cell bodies are in the dorsal root ganglia (DRG). These free
nerve endings in the epidermis and upper dermis can be activated
by a variety of stimuli, including proteases, neurotrophins,
cytokines and other small molecules (reviewed in [3]).
The mechanisms for enhanced itch sensations in atopic
dermatitis are unclear. One potential mechanism is an increase
in nerve endings in atopic dermatitis skin [4]. Specifically, there
are more nerve fibers in the papillary and upper dermis as disease
progresses from clinically normal-appearing, or non-lesional, skin to
active disease, or lesional, skin [5].
Eosinophils have been linked to atopic dermatitis for well over
forty years, due to high numbers circulating in the blood of atopic
dermatitis patients [6]. Serum concentrations of eosinophil granule
proteins correlate with the severity of atopic dermatitis [7,8], and
peripheral blood eosinophils from patients have more neurotro-
phin receptors and more functional activity in response to
neurotrophins than eosinophils from healthy controls [9]. Intact
eosinophils are not found in high numbers in atopic dermatitis
biopsies, leading some to question whether these cells have a role
in the pathogenesis of this disease. However, the presence of
eosinophil granule proteins in lesional skin suggests that activated
eosinophil are present, but not identifiable, having degranulated
[10,11].
Previously, we showed that eosinophils interact with nerves in
the airways of patients with asthma, in animal models of asthma,
and in culture. Eosinophils are found adjacent to nerves in airway
biopsies of humans who died from asthma attacks, a histological
finding that is recapitulated in antigen-challenged guinea pigs and
rats [12]. Primary cultures of parasympathetic neurons from
guinea pig and human airways express eotaxin-1, as well as
ICAM-1 and VCAM-1, and these participate in binding of
eosinophils to neurons [13,14]. The association of eosinophils with
airway nerves is important in the pathophysiological changes that
lead to airway hyperreactivity [12,15].
Eosinophils communicate with other cell types through a variety
of specific signals. They can act as antigen-presenting cells, release
cytokines and chemokines after activation, or release granule
proteins, such as major basic protein (MBP) and eosinophil
peroxidase (EPO) [16,17]. They also constitutively synthesize
specific neurotrophins, including nerve growth factor (NGF),
brain-derived neurotrophic factor (BDNF), and neurotrophin-3
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stimulation [9,18].
In this study, we investigated the physical and functional
relationship between eosinophils and sensory nerves in the skin of
humans with atopic dermatitis, in a mouse model of atopic
dermatitis, and in co-cultures of eosinophils with primary sensory
neurons. We report here that eosinophil granules are located near
neurons in the upper, or papillary, dermis of human skin, the
region in which nerves are also increased. In a transgenic mouse in
which IL-5 is driven by a K14 promoter, eosinophils localize to the
epidermis and lead to increased nerves in this region. In culture,
eosinophils directly cause branching of sensory neurons, through a
mechanism that does not involve NGF. These data indicate a
potential mechanism and therapeutic target for the increase in
nerves seen in human atopic dermatitis.
Results
Human skin biopsies are representative of healthy skin
and different stages of atopic dermatitis
Skin biopsies were gathered from five healthy volunteers and six
subjects with atopic dermatitis. Patients with atopic dermatitis had
not used topical corticosteroids for a minimum of a week before
the biopsies were taken. Each subject was examined by a
dermatologist and confirmed to have atopic dermatitis, both by
clinical exam and patient and family history. All atopic dermatitis
subjects were previously diagnosed with the Hanifin and Rajka
criteria [1]. One biopsy was taken from each healthy control, and
two were taken from each atopic dermatitis subject, for paired
lesional (L) and non-lesional (NL) skin. Non-lesional skin
throughout this report refers to normal appearing skin from an
atopic dermatitis patient. Subject characteristics and biopsy sites
are shown in Table 1. All patients had positive family and personal
history for atopic dermatitis, including allergies and asthma.
Hematoxylin and eosin (H&E) staining of the human skin biopsies
confirmed the clinical diagnoses of healthy control, non-lesional
atopic dermatitis or lesional atopic dermatitis (Figure 1A).
Atopic dermatitis lesional skin biopsies have more nerves
than non-lesional skin from the same subjects
Biopsy sections were stained with an antibody to the pan-
neuronal marker PGP9.5. Photographs were taken along the
length of the skin section, and nerves staining positively for
PGP9.5 were counted in the papillary dermis and basement
membrane zone of the skin. Representative photomicrographs of
normal, non-lesional and lesional skin are shown with quantifica-
tion (Figure 1 B, C). Nerves were increased, both in number and in
length, in lesional atopic dermatitis skin, compared to each non-
lesional skin sample from the same patient. Overall, nerves were
also increased compared to healthy control skin, except for one
healthy control with many more cutaneous nerves. It may be
significant that this outlier subject had high numbers of eosinophils
in the blood and also had increased eosinophil granule proteins in
the skin.
Atopic dermatitis skin biopsies have more eosinophil
granule proteins, which are located around nerves in the
papillary dermis
In order to determine if eosinophil localization to nerves in the
skin occurs in atopic dermatitis biopsies, we first performed single
immunohistochemistry with an antibody to eosinophil peroxidase
(EPO), a protein present in eosinophil granules. EPO was present
in lesional atopic dermatitis skin at higher quantities than normal
or non-lesional skin, and it was often located in the papillary
dermis (Figure 2 A,B and Table 2). This localization correlated
with both the location and stage of disease in which nerves are
increased. Intact eosinophils were present in some lesional skin
sections, more often in blood vessels (data not shown), suggesting
that eosinophils that have migrated into tissues tended to
degranulate. In addition, double immunohistochemistry for
eosinophil peroxidase and PGP9.5 determined that eosinophil
peroxidase could be found around nerves in the papillary dermis,
especially in lesional skin samples (Figure 2C).
Mast cells are increased in non-lesional atopic dermatitis
skin and are not increased in lesional skin
Because mast cells are found in the skin in association with
nerves, under both normal and pathological conditions [19,20],
and previous reports have shown mast cells are increased in
lesional skin compared to healthy controls [21,22], we stained
biopsies with toluidine blue. A non-significant trend toward more
mast cells was seen in non-lesional atopic dermatitis skin, but not
in lesional skin (Figure 3).
Nerves are increased in the epidermis of a transgenic
mouse that expresses IL-5 in basal keratinocytes
NJ.692 mice were generated to constitutively express IL-5 under
the control of keratin 14 regulatory elements in basal keratino-
cytes. The mice have mild peripheral blood eosinophilia with
greater than 30-fold increased numbers of eosinophils in the skin.
Some mice develop spontaneous skin lesions and clinically
apparent inflammation. These animals also have deposition of
eosinophil granule proteins in the skin, predominantly in the
epidermis, which can be detected using anti-MBP antibodies
(figure 4C).
We examined skin sections from these mice for the number of
nerves and found that they have more nerves in the epidermis and
basement membrane zone than wild-type controls, but similar
numbers of nerves in the dermis (Figure 4). Thus the increase in
nerves was seen in the same regions where IL-5 was expressed and
where eosinophils were located.
Eosinophils increase sensory neuron branching in vitro
The cell bodies of the sensory neurons that innervate the skin are
located in the dorsal root ganglia (DRG), and these were dissected
Table 1. Human skin biopsies.
Subject Skin type Samples taken Region
001 Atopic Dermatitis Lesional/Non-lesional Flexor knee
002 Healthy Control Normal Interior arm
003 Healthy Control Normal Interior arm
004 Atopic Dermatitis Lesional/Non-lesional Flexor knee
005 Atopic Dermatitis Lesional/Non-lesional Flexor elbow
006 Atopic Dermatitis Lesional/Non-lesional Exterior arm
007 Healthy Control Normal Interior arm
008 Healthy Control Normal Interior arm
009 Healthy Control Normal Interior arm
010 Atopic Dermatitis Lesional/Non-lesional Interior arm
011 Atopic Dermatitis Lesional/Non-lesional Extensor
elbow
doi:10.1371/journal.pone.0022029.t001
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Matrigel. Blood was taken from NJ1638 mice, in which the IL-5
gene is expressed under the control of the CD3d promoter, leading
to high levels of circulating eosinophils [23]. Eosinophils were
isolated using density centrifugation and fluorescence-activated cell
sorting (FACS) of unstained cells based on size and granularity.
Eosinophils were added to DRG cell cultures for twenty-four hours.
The cultures were then fixed, stained with PGP9.5, and the number
of cell bodies, length of neurites, number of neurites per cell body,
and number of branchpoints per neurite were quantified by an
observer who was blinded to the experimental condition. Neurons
grown with eosinophils had dramatically increased neurite
branching, compared to neurons grown alone (Figure 5 A, B).
The number of cell bodies, number of neurites per cell body and the
length of the longest neurite were not significantly different between
neurons alone or neurons with eosinophils (data not shown). There
was also no difference in DRG cell survival with or without
eosinophils (data not shown).
Mast cells do not increase neuron branching in vitro
Since mast cells were localized around nerves in human skin
biopsies, we isolated mast cells from the peritonea of wild-type
Figure 1. Atopic dermatitis lesional skin has more nerves than paired non-lesional skin. (A) Human skin biopsies are typical of healthy
control skin (left), non-lesional atopic dermatitis (center), and lesional atopic dermatitis (right). (B) Nerves were stained (in gray), and representative
sections are shown of healthy control (left), non-lesional (center) and lesional atopic dermatitis (right). (C) Quantification of number and lengtho f
nerves in healthy control or atopic dermatitis skin. Paired t-test was performed between lesional and non-lesional skin biopsies from the same
subject. Outlier control subject with high blood eosinophils and increased nerves is represented by diamond. * denotes significantly different from
control. Scale bar in photographs=50 um.
doi:10.1371/journal.pone.0022029.g001
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were stained with anti-EPO antibody (dark red-brown). A representative photomicrograph is shown of lesional skin. B) Quantification of EPO-positive
clusters in skin. C) Representative photomicrographs of double immunohistochemistry using anti-PGP9.5 (black) for nerves and anti-EPO (red-brown).
Top panels are two samples of healthy control skin. Bottom panels are two lesional atopic dermatitis samples. Bottom left shows a nerve with EPO+
cells nearby, while bottom right shows a nerve overlaid with EPO. * denotes significantly different from control. Scale bar=50 um.
doi:10.1371/journal.pone.0022029.g002
Eosinophils and Nerves in Atopic Dermatitis
PLoS ONE | www.plosone.org 4 July 2011 | Volume 6 | Issue 7 | e22029mice and added them, in the same numbers as eosinophils, to the
neuron cultures for twenty-four hours. Mast cells did not increase
neurite branching (Figure 5C).
Eosinophils must be alive to increase neuron branching,
but physical contact is not required
In order to determine whether the eosinophils needed to be
alive to have this effect on neurite branching, we freeze-fractured
eosinophils and added them to neuronal cultures for twenty-four
hours. Eosinophils killed in this way did not increase neurite
branching (Figure 5D). Adding culture medium from eosinophils
plated on Matrigel for twenty-four hours to DRG cultures
increased neuron branching, indicating that the morphological
changes do not require cell contact, and adding culture medium
from co-cultures of DRG neurons with eosinophils to fresh DRG
cultures further increased the amount of neurite branching
(Figure 5E).
Blocking nerve growth factor (NGF) does not inhibit
eosinophil-induced neurite branching
Adding exogenous murine NGF (40 ng/ml) to DRG cultures
increased neurite branching, and this effect was blocked by an
antibody to NGF (20 ug/ml) (Figure 5F). However, adding the
same concentration of anti-NGF to DRG cultures co-cultured with
eosinophils (Figure 5F) or treated with eosinophil culture medium
(data not shown) did not prevent the increase in neurite branching.
Thus NGF production by eosinophils was not responsible for the
effect on nerve branching.
Neurons from dorsal root ganglia produce eotaxin-1,
ICAM-1 and VCAM-1
DRG neurons were cultured alone for twenty-four hours and
stained for eotaxin-1, a chemokine that acts through the CCR3
chemokine receptor on eosinophils [24,25]. Neurons synthesized
eotaxin-1, both in the presence and absence of exogenous NGF
(Figure 6A). In addition, neurons also produced the adhesion
molecules ICAM-1 and VCAM-1, but only when exogenous NGF
was added to the cultures (Figure 6B, C). This indicates a regulated
expression of adhesion molecules that could be affected by the
presence of eosinophils or other cells that express NGF [9,26].
Discussion
Our data demonstrate for the first time that eosinophils can
dramatically increase sensory neuron branching, and that this
effect is important in eosinophilic skin diseases, such as atopic
dermatitis. We found that there were more nerves in lesional
versus non-lesional atopic dermatitis, which correlated with the
amount and location of eosinophil granule proteins. In transgenic
mice that express IL-5 driven by a K14 promoter, both eosinophils
and increased innervation were localized to the epidermis. Finally,
eosinophils dramatically increased neurite branching in cultured
dorsal root ganglion sensory neurons. The ability of eosinophils to
promote neurite branching in sensory neurons in culture supports
the role of eosinophils in the neural changes in atopic dermatitis.
Sensory neuron expression of ICAM-1 and VCAM-1, as well as
eotaxin-1, suggests active recruitment of eosinophils to the nerves,
as we have previously demonstrated for parasympathetic neurons
in the airways [13].
Our biopsies were taken from several places anatomically, and
the control patients’ biopsies were all taken from the inner arm
(Table 1). While this might have affected the number of nerves, the
regional variation in cutaneous nerve density would favor more
nerves in the arm than in the leg [27], and we found the opposite
when comparing atopic dermatitis biopsies to control biopsies.
Although there was a general increase in cutaneous mast cells in
our human skin biopsies, unlike the eosinophils cutaneous mast
cells were not increased in the lesional skin, where nerves were
increased. This finding, along with the failure of mast cells to
promote nerve branching in vitro, suggests that eosinophils are
more likely responsible.
In human and mouse skin, we did not identify which types of
nerves were increased in number, although the locations of these
Table 2. Eosinophil peroxidase (EPO) staining in human skin
biopsies.
Name of sample
avg # EPO+
clusters EPO+ regions of skin
NORMAL:
002 normal 1.5 papillary dermis
003 normal 0.6 basement membrane zone
008 normal 0.25 papillary dermis
009 normal 1 reticular dermis
NON-LESIONAL
001 non-lesional 1.8 papillary dermis
004 non-lesional 2.43 papillary dermis
005 non-lesional 2.36 papillary dermis
006 non-lesional 3 papillary+reticular dermis
011 non-lesional 1.833 papillary dermis
LESIONAL
001 lesional 2.5 papillary+reticular dermis
004 lesional 5.08 papillary+reticular dermis
005 lesional 2.3 papillary+reticular dermis
006 lesional 3.125 papillary+reticular dermis
010 lesional (unpaired) 4.36 papillary dermis
011 lesional 2.75 papillary dermis
doi:10.1371/journal.pone.0022029.t002
Figure 3. Mast cells in controls and atopic dermatitis patients.
A non-significant increase in mast cells was seen in biopsies of non-
lesional skin in atopic patients. There was no increase in mast cells in
lesional skin.
doi:10.1371/journal.pone.0022029.g003
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zone would suggest sensory origins. However, our culture
experiments specifically examined the branching of sensory
neurons with cell bodies in the dorsal root ganglia, which include
the itch-specific C-type neurons [2,28,29].
Itch-specific C-type neurons are reported to have more highly
branching terminals, enabling them to innervate exceptionally
large regions of tissue [29]. It is possible that eosinophils are not
simply stimulating neurite growth but are causing a shift in the
phenotype of the affected neurons. A precedent for this type of
shift lies in hyperalgesia and allodynia, in which changes in
neurotransmitter release, ion channel regulation and threshold
for stimulation lead to perception of non-painful stimuli as pain
[30,31].
We showed that NGF was not the necessary factor for
eosinophil-induced neurite branching using a blocking antibody
that has less than 1% cross-reactivity for BDNF and neurotrophins
3 and 4 (NT-3, NT-4). However, eosinophils synthesize other
neurotrophins, including BDNF and NT-3 [18,32], as well as
interleukins and other mediators that could be responsible for
nerve growth. Thus there may be considerable redundancy in this
system, as well as the possibility that other, non-neurotrophin
eosinophil products, are involved. For example, major basic
protein, the principal constitutent of the eosinophil granule,
Figure 4. Keratin 14-Interleukin 5 mice have eosinophil major basic protein (MBP) primarily in the epidermis, and have more nerves
in epidermis and basement membrane zone than wild-type controls, but similar numbers in the dermis. 5 um skin sections on slides
were stained using anti-MBP (red, in top three sections) and anti-PGP9.5 to visualize nerves (brown, in bottom three sections). Photographs of each
entire section were taken, and random numbers assigned to each for quantification of nerves by an observer blinded to the genotype. (A and D) IgG
negative control, (B) anti-MBP staining of wild type mouse,(C) anti-MBP staining of K14-IL-5 skin section. MBP staining is largely seen in the epidermis,
which is where the IL-5 is expressed. (E) PGP9.5 stained wild type mouse, (F) PGP9.5 stained K14-IL-5 skin section. Note the extensive linear nerves
from the basement membrane zone through many layers of the epidermis. (G) Quantification of nerves shows an increase in the epidermis (where IL-
5 is expressed and eosinophil major basic protein is seen) but not in the dermis. Scale bars=50 mM.
doi:10.1371/journal.pone.0022029.g004
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muscarinic receptors on the nerves [15], increasing sensory nerve
excitability [33], and activating p38 MAP kinase [34]. The effects
of major basic protein, as well as other eosinophil granule proteins
and non-granule products, is not known.
Our findings are also important for other eosinophilic skin
diseases, several of which induce itch as a predominant symptom.
Itchy papular eruptions have been described in the hypereosino-
philic syndrome (HES) and can be successfully treated with
ultraviolet (UV) therapy [35]. In prurigo nodularis, a disease
defined solely by its itchiness, large deposits of eosinophil cationic
protein (ECP) and EDN were detected by immunofluorescence.
Intact eosinophils were often located near nerves, and there was an
increase in the number of nerves in areas with many eosinophils
[36]. Finally, a disease called equine sweet itch results from
sensitization to the bite of the midge and subsequent ‘‘challenge’’
or further bites. Eosinophils are recruited by eotaxin and MCP-1,
which are expressed in the skin of sensitized horses, and horses
scratch, rub and bite the lesions, which results in skin thickening
and hair loss [37].
Our report demonstrates the role of eosinophils in nerve
branching in vivo and in vitro, and strongly suggests that this is
relevant to human skin diseases, including atopic dermatitis, in
which eosinophils and nerves are found together. The ability of
Figure 5. Eosinophils increase branching of dorsal root ganglion (DRG) neurites. (A) Mouse DRG neurons were isolated and co-cultured
with eosinophils for 24 hours. Cells were fixed and stained with anti-PGP9.5 to visualize neurons. DRG neurons cultured with eosinophils (right)
showed dramatic increases in neurite branching, compared to DRG neurons cultured alone (left). (B) Quantification of number of branchpoints per
cell body, n=7. * denotes significantly different from DRG alone, ** denotes significantly different from DRG+NGF. (C) Mast cells were isolated from
the peritonea of wild-type mice and added to DRG neuron cultures for 24 hours. Slides were stained and quantified as above. n=4. (D) Eosinophils
were resuspended in sterile deionized water and freeze-thawed twice, resuspended in culture medium and added to DRG neuron cultures for
24 hours. n=2. (E) Culture medium from eosinophils cultured alone or with DRG for 24 hours was applied to new DRG cultures for 24 hours. n=4. (F)
DRG neurons were plated and incubated alone (white bar), with 40 ng/ml NGF (gray solid bar), with NGF and 20 ug/ml anti-NGF (gray hatched bar),
with eosinophils (black bar), or with eosinophils and 20 ug/ml anti-NGF (black hatched bar) for 24 hours. n=2. * denotes significant one-way ANOVA
across all groups.
doi:10.1371/journal.pone.0022029.g005
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and stained with anti-eotaxin-1 (red). Cell nuclei were counterstained using DAPI (blue). Two representative photomicrographs are shown. Scale
bars=50 um. (B–C) DRG neurons were cultured alone or with 40 ng/ml NGF for 24 hours, then fixed and stained with anti-ICAM-1 (B) or anti-VCAM-1
(C). Left, no primary with secondary negative control; center, DRG stained with antibody in cultures without exogenous NGF; right, DRG stained with
antibody in cultures with NGF added. GRAPH: Quantification of relative fluorescence units, compared to background and to negative controls, was
performed using Metamorph.
doi:10.1371/journal.pone.0022029.g006
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that interact with eosinophils suggests potential drug targets in
eosinophil-related skin diseases.
Methods
Human Skin Biopsies
Human studies were approved by the Institutional Review Board
of Oregon Health & Science University (IRB approval #2568), and
all patients gave written informed consent. Healthy subjects and
atopic dermatitis patients were interviewed for their personal and
family history of atopy and then examined by a dermatologist to
determine extent of disease. A self-reported history of atopy was
required for inclusion as an atopic dermatitis patient, and all
patients had a previous diagnosis of atopic dermatitis by
dermatologists at OHSU. Four millimeter punch biopsies were
removed from areas of normal-appearing (non-lesional) or active
(lesional) disease. Biopsies of normal skin from healthy subjects were
taken from the inner arm or behind the knee. All biopsies werefixed
in 10% neutral buffered formalin and embedded in paraffin.
Human Skin Immunocytochemistry
5 um paraffin sections were cut onto slides, and these were
rehydrated through xylenes and sequential ethanol dilutions.
Antigen unmasking solution was used according to the protocol,
[Vector], and 3% hydrogen peroxide in methanol was applied for
ten minutes, to quench endogenous peroxidase activity. Sections
were blocked with 10% normal goat serum, and mouse anti-
human protein gene product 9.5 (PGP9.5) [Serotec] was applied
overnight at 4uC. Slides were rinsed in PBS and biotinylated goat
anti-mouse IgG was applied for 30 minutes at room temperature.
The Vectastain ABC kit and chromogenic substrates were used to
visualize positive antibody staining. Slides were rinsed in tap
water, then dehydrated through ethanol dilutions and xylenes.
Slides were mounted using Cytoseal CrystalMount and dried
overnight. Likewise, human skin biopsies stained for eosinophil
peroxidase (EPO) were blocked and incubated with antibody at
4uC overnight, then treated identically as PGP9.5-stained slides.
Sections stained for both EPO and PGP9.5 were treated with the
avidin-biotin blocking kit from Vector to prevent non-specific
signal. Sections used for H&E or mast cell identification were
deparaffinized and rehydrated as above and then stained using
hematoxylin and eosin or toluidine blue.
Semi-quantitative Analysis of Immunostaining of Human
Skin
406or 606photomicrographs were taken of the entire region of
each skin biopsy. Measurements were taken of papillary dermis,
reticular dermis, hypodermis, and epidermal-dermal zone; howev-
er, only measurements of papillary dermis and epidermis/basement
membrane are reported. Nerve length was calculated by calibrating
each photograph to the objective with which it was taken and then
drawing a straight line between the two furthest pointsofa PGP9.5-
positive nerve, using Metamorph software. Nerve number was
counted manually. Data were reported as average number of nerves
per photo, and average length of nerve per photo. Mast cells were
counted in double-stained 606 photographs, and proximity to
nerves measured using Metamorph software. Fifteen microns, or
approximately half a mast cell’s diameter, was determined to be the
limit of ‘‘association’’ between a mast cell and nerve.
Animals
Female wild-type C57BL/6 mice, 6–8 weeks of age, were
purchased from Jackson Laboratories. NJ.1638 IL-5 transgenic
mice, in which the full murine IL-5 sequence, with every intron
and 1.2 kb of 39-flanking sequences, but none of the upstream
known regulatory elements, is regulated by the promoter and
tissue-specific enhancer for CD3d, overexpresses IL-5 in T cells.
These mice were generated, bred and genotyped as previously
described (67). NJ.692 mice (K14/IL5 transgenic mice) were
generated by creating a plasmid construct containing the 1.9 kb
K14 promoter (provided by Dr. Elaine Fuchs [38] fused to the IL-
5 gene. The plasmid insert was injected into mouse embryos
following excision from the plasmid vector. Mice were bred with
C57Bl/6J mice (Jackson Laboratories) and maintained using either
Southern analysis of BamHI digested tail DNA blotted to
radioactively labelled IL-5 cDNA or PCR reactions using primers
specific for the IL-5 injected DNA. PCR primers were (K14) 59
TTG GCG CTA GCC TGT GGG 39 and (IL5 beta 2) 59 CAG
CCT ACC CTA CAT AGC AAG TTT G 39. All animal
experiments were approved by the Institutional Animal Care and
Use Committee of Oregon Health & Science University (approval
# B11249), and were performed in accordance with National
Institutes of Health and Mayo Foundation institutional guidelines.
Mouse skin immunocytochemistry
Skin sections from mice were fixed in 4% formaldehyde and
embedded in paraffin. Five micron sections were immunostained
in the same manner as human skin, using rabbit anti-mammal
PGP9.5 and biotinylated goat anti-rabbit IgG. Sequential samples
were double-stained with PGP9.5 and major basic protein (MBP)
antibodies generated in the Lee Laboratory. Rat anti-mouse MBP
was applied overnight at 4uC, and secondary antibody, conjugated
to the fluorophore Alexa Fluor-555, was applied for 2 hours at
37uC. Slides were rinsed in PBS, and mounted using Vectastain
with DAPI, to stain cell nuclei.
Semi-quantitative analysis of mouse skin
immunohistochemistry
606 photographs of entire mouse skin biopsies were taken.
Slides were de-identified using an algorithm assigning random
numbers to each photograph, and measurements were taken of
PGP-positive spots in the papillary dermis, reticular dermis, and
epidermal-dermal zone of each blinded photograph by an
investigator blinded to the condition of the biopsy. Nerve length
was calculated by calibrating each photograph to the 606
objective and then drawing a straight line between the two
furthest points of a PGP 9.5-positive nerve, using Metamorph
software. Nerve number was counted manually. Data from each
photograph were averaged to determine the mean number of
nerves per photo, sum of nerve lengths per photo, and average
length of nerve per photo. Each photograph was de-coded after all
measurements and calculations were completed. Quantification of
nerves per area or nerves per length of basement membrane did
not give different results from number of nerves per photo.
Isolation of Dorsal Root Ganglia (DRG)
Dorsal root ganglia were isolated according to modifications of
previous published protocols [39,40]. Cervical, thoracic and
lumbar DRG were dissected from the spines of wild-type
C57BL/6 mice and incubated in 0.05% collagenase at 37uC for
four hours, centrifuged at 3006g for 10 minutes at room
temperature, and resuspended in 3 ml 1.25% Trypsin-EDTA for
15 minutes at 37uC. Cells were centrifuged again and resuspended
in DMEM, 10% FBS, penicillin-streptomycin, and pre-plated.
The next day, non-adherent cells were centrifuged and resus-
pended in C2 nerve growth medium that contained penicillin-
Eosinophils and Nerves in Atopic Dermatitis
PLoS ONE | www.plosone.org 9 July 2011 | Volume 6 | Issue 7 | e22029streptomycin, at a concentration of 5610
5 cells/ml. Nerves were
plated on Matrigel-coated chamber slides. Murine NGF was
added to some cultures at a concentration of 40 ng/ml. Sheep
anti-NGF was added for a final concentration of 20 ug/ml. At the
end of each experiment, cells were fixed in 4% paraformaldehyde
for 5 minutes.
Isolation of murine blood eosinophils
Diluted blood from NJ.1638 (IL-5 transgenic) mice was layered
over 15 mL sterile Percoll (density 1.084 g/mL) and centrifuged at
20006g for 45 minutes. The white layer at the interface, which
contained the granulocytes, was collected, washed and centrifuged
at 3006g for 15 minutes at 4uC. Red cells were lysed and the
eosinophils were isolated by size and granularity using fluores-
cence-activated cell sorting (FACS). Trypan blue exclusion was
used to determine viability. Percent purity was determined by
Hemacolor assay on cytospin slides. After FACS staining, percent
purity of eosinophils was determined by Hemacolor staining and
differential cell counts under the 206 objective of a bright field
microscope. The purity of eosinophils after sorting was 91%. Cells
were resuspended in C2 nerve medium at the indicated
concentrations and added to cultures of DRG neurons for
24 hours.
Isolation of murine peritoneal mast cells
Peritoneal mast cells were isolated according to the method of
Jensen et al. [Jensen B, Swindle E, Iwaki S, Gilfillan A, Current
Protocols in Immunology, 2006, Wiley Interscience]. A single
mouse was killed and the peritoneum was lavaged with HBSS.
Lavage fluid was centrifuged at 4006g for 5 minutes, red blood
cells were lysed, and the cells were washed twice with HBSS. The
pellet was resuspended in 70% isotonic Percoll solution, and cells
were layered over filter-sterilized peritoneal mast cell (PMC)
medium (DMEM, 5% FBS, 2 mM L-glutamine, 50 ug/ml
gentamicin, 20 mM HEPES) and centrifuged at 5806g for
15 minutes at room temperature. The mast cell pellet was
resuspended in PMC medium. Aliquots of cells were counted
and stained with trypan blue to determine viability or toluidine
blue to determine purity of mast cells. Finally, cells were adjusted
to indicated concentrations, added to slides or wells and incubated
at 35.5uC with 5% CO2.
Dorsal Root Ganglion Immunocytochemistry
Slides with DRG were fixed in 4% paraformaldehyde for
5 minutes, rinsed with HBSS with calcium and magnesium, and
stored in PBS until stained. Slides were blocked with 10% serum
and stained with antibodies to PGP 9.5, ICAM-1, VCAM-1, or
eotaxin-1 overnight at 4uC. After rinsing in PBS, a secondary
antibody conjugated to Alexa Fluor-555, or biotin, was applied.
Slides were rinsed and either mounted in Vector Mounting
Medium with DAPI, to stain cell nuclei, or completed, using
Vector Vectastain Avidin-Biotin Complex immunohistochemistry
kit and mounted.
Dorsal Root Ganglion Imaging and Quantification
Thirty 406photographs were taken of each chamber after each
treatment, stained with anti-PGP 9.5 antibody. Photographs were
always taken beginning in the center of each well of a 4-well
chamber slide, and then every subsequent field of view was
photographed, in the same defined pattern for all slides. Using
Metamorph, numbers of cell bodies, neurites, and branchpoints
per cell body were counted manually. Each cell body in each
photograph was quantified. In addition, neurite length was
measured with the segmented line function, which allowed the
neurite to be traced from end to end and measured according to
the pixel per micron ratio for the 406objective. The mean of each
measurement (number of cell bodies, neurites, branchpoints and
neurite length) for all cell bodies in thirty pictures was determined.
Verification of this method was provided two ways: first, one
group of photographs each from two experiments was quantified
by a blinded observer, who knew neither the treatment groups nor
the predicted outcome, and second, photographs were taken at
random places in each well for one experiment, and a blinded
observer then performed the measurements. Blinded observations
were found to match unblinded observations.
Statistical Analysis of Data
All data are expressed as mean +/2 SEM. Comparisons
between two groups were made using t-tests for unpaired data,
while comparisons of nerves in lesional and non-lesional skin from
the same human were made using paired t-tests. Multiple
comparisons used one-way ANOVA, with a Tukey’s post-test to
evaluate differences between groups. A p value of less than 0.05
was considered statistically significant.
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